GLP-1 diabetes drugs likely trump metformin for curbing dementia risk in type 2 diabetes, study finds

GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for curbing dementia risk in people with the condition, finds the largest study of its kind, published in the open access journal BMJ Open Diabetes Research & Care.

source https://medicalxpress.com/news/2025-07-glp-diabetes-drugs-trump-metformin.html